Low Dose Allergy Immunotherapy (LDI)

Low Dose Allergy Immunotherapy (LDI) for Lyme Disease

LDI is an extremely low dose immunotherapy that uses broad-based mixtures of allergens (antigens) made immunologically active by the enzyme glucuronidase. Allergy occurs when the immune system no longer tolerates the external environment. Auto Immune Disease  Autoimmune disease occurs when the immune system no longer tolerates the internal environment of the body. LDI helps restore immune tolerance to the environment outside and inside the body.

More about LDI Treatment:

• Read More about LDI Here
• LOW DOSE IMMUNOTHERAPY: NEW THERAPY FOR LYME DISEASE TREATMENT AVAILABLE AT RESTORMEDICINE
• Low Dose Immunotherapy (LDI): Changing The Game In Lyme Disease
• LDI: Bring on The Regulators

Patient Experience

Click “View Results” at the bottom of Poll

The Low Dose Immunotherapy Handbook: Recipes and Lifestlye Advice for Patients on LDA and EPD Treatment

Back To:

Lyme Disease Protocols, and Healing Aids